Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T06:02:52.947Z Has data issue: false hasContentIssue false

Chapter 11 - Renal Diseases Associated with Hematopoietic Disorders or Organized Deposits

Published online by Cambridge University Press:  01 March 2017

By
Guillermo A. Herrera
Edited by
Xin Jin (Joseph) Zhou ,
Zoltan G. Laszik ,
Tibor Nadasdy  and
Vivette D. D'Agati
Xin Jin (Joseph) Zhou
Affiliation:
Baylor University Medical Center, Dallas
Zoltan G. Laszik
Affiliation:
University of California, San Francisco
Tibor Nadasdy
Affiliation:
Ohio State University
Vivette D. D'Agati
Affiliation:
Columbia University, New York
Get access
Type
Chapter
Information
Silva's Diagnostic Renal Pathology , pp. 385 - 448
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kyle, RA. Multiple myeloma: How did it begin? Mayo Clin Proc 1994; 69:680–3.Google Scholar
Sanders, PW, Herrera, GA, Kirk, KA, Old, CW, Galla, JH. The spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991; 64:527–37.Google Scholar
Buxbaum, JN, Chuba, JV, Hellman, C, Solomon, A, Gallo, GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Ann Int Med 1990; 112:455–64.CrossRefGoogle ScholarPubMed
Sanders, PW, Herrera, GA. Monoclonal immunoglobulin light chain-related renal diseases. Sem Nephrol 1993; 13:324–41.Google Scholar
Herrera, GA. Renal manifestations on plasma cell dyscrasias: an appraisal of the patients’ bedside to the research laboratory. Annals Diagn Pathol 2000; 4:174–200.CrossRefGoogle Scholar
Lin, J, Markowitz, GS, Valeri, AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001; 12:1482–92.Google Scholar
Markowitz, GS. Dysproteinemia and the kidney. Adv Anat Pathol 2004; 11:49–63.CrossRefGoogle ScholarPubMed
Korbet, SM, Schwartz, MM. Multiple myeloma. J Am Soc Nephrol 2006; 17:2533–45.Google Scholar
Kyle, RA, Therneau, TM, Rajkumar, SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354:1362–9.Google Scholar
Landgren, O, Graubard, BI, Katzman, JA, et al. Racial disparity in the prevalence of monoclonal gammopathies: A population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia 2014; 28:1537–42.Google Scholar
Kyle, RA. Monoclonal gammopathy of undetermined significance: Natural history in 241 cases. Am J Med 1978; 64: 814–26.Google Scholar
Kyle, RA, Therneau, TM, Rajkumar, SV. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346:564–9.Google Scholar
Herrera, GA, Sanders, PW, Reddy, BV, et al. Ultrastructural immunolabeling: A unique diagnostic tool in monoclonal light chain related renal diseases. Ultrastruct Pathol 1994; 18:401–16.CrossRefGoogle ScholarPubMed
Herrera, GA. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions. Med Elect Mic 2001; 34:1–18.Google Scholar
Leung, N, Bridoux, F, Hutchinson, CA, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 2012; 4292–5.Google Scholar
Eulitz, M, Weiss, DT, Solomon, A. Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci USA 1990; 87:6542–6.CrossRefGoogle ScholarPubMed
Randall, RE, Williamson, WC, Mullinax, F, Tung, MY, Still, WJS: Manifestations of systemic light chain deposition. Am J Med 1976; 60:293–9.Google Scholar
Copeland, JN, Kouides, PA, Grieff, M, Nadasdy, T. Metachronous development of nonamyloidotic lambda light chain deposition disease and IgG heavy chain amyloidosis in the same patient. Am J Surg Pathol 2003; 27: 1477–82.CrossRefGoogle Scholar
Nasr, SH, Colvin, R, Markowitz, GS. IgG1 lambda light and heavy chain renal amyloidosis. Kidney Int 2006; 70:7.CrossRefGoogle ScholarPubMed
Cohen, AH. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease. Am J Kidney Dis 1998; 32:529–32.Google Scholar
Nayer, A, Green, DF, Gonzalez-Suarez, ML, et al. Tubulointerstitial nephritis accompanying gamma-heavy chain restricted plasma cells in the kidney. Iran J Kid Dis 2014; 8:417–23.Google Scholar
Kyle, RA, Beard, CM, O’Fallen, WM, Kurland, LT. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with review of trend since 1945. J Clin Oncol 1994; 12: 1577–83.CrossRefGoogle ScholarPubMed
Rajkumar, SV, Dimopoulos, MA, Palumbo, A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15:E538–48.Google Scholar
Blade, J, Kyle, RA. Nonsecretory myeloma, immunoglobulin D myeloma and plasma cell leukemia. Hematol Oncol Clin North Am 1999; 13:1259–72.Google Scholar
Rayner, HC, Haynes, AP, Thompson, JR. Perspectives in multiple myeloma: Survival, prognostic factors and disease complications in a single center between 1975 and 1988. Quart J Med 1991; 79:517–25Google Scholar
Kapadia, SB. Multiple myeloma: A clinicopathic study of 62 consecutively autopsied cases. Medicine (Baltimore) 1980; 59:380–92.Google Scholar
Ivanyi, B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114:986–7.Google Scholar
Herrera, GA, Joseph, L, Gu, X, Hough, A, Barlogie, B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasias. Arch Pathol Lab Med 2004; 128: 875–9.Google Scholar
Herrera, G, Gu, X. Lesions associated with plasma cell dyscrasias in renal biopsies: A 10 year retrospective study. Lab Invest 2006; 86:262A.Google Scholar
Herrera, GA. Proximal tubulopathies associated with monoclonal light chains: The spectrum of morphological manifestations and molecular pathogenesis. Arch Pathol Lab Med 2014; 138: 1365–80.Google Scholar
Gu, X, Herrera, GA. Light chain-mediated acute tubular interstitial nephritis: A poorly recognized pattern of renal disease in patients with plasma cell dyscrasia. Arch Pathol Lab Med 2006; 130:165–9.CrossRefGoogle ScholarPubMed
Kapur, U, Barton, K, Fresco, R, et al. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med 2007; 131: 1368–72.Google Scholar
Larsen, CP, Bell, JM, Harris, AA, et al. The morphologic and clinical significance of light chain proximal tubulopathy with and without crystal formation. Mod Pathol 2011; 24:1482–9.Google Scholar
Stokes, MB, Valeri, AM, Herlitz, L, et al. Light chain proximal tubulopathy: Clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol 2015; 27: Epub ahead of print.Google Scholar
Sanders, PW, Herrera, GA, Galla, JH. Human Bence Jones protein toxicity in rat proximal epithelium in vivo. Kidney Int 1987; 32:851–61.Google Scholar
Ronco, PM, Aucouturier, P. The molecular basis of plasma cell dyscrasia-related renal diseases. Nephrol Dial Transplant 1999; 14(Suppl): 4–8.Google Scholar
Stokes, MG, Aronoff, B, Siegel, D, D’Agati, VD. Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis. Kidney Int 2006; 70:597–602.Google Scholar
Harrison, JF, Blainey, JD. Adult Fanconi Syndrome with monoclonal abnormality of immunoglobulin light chain. J Clin Pathol 1967; 20:42–8.Google Scholar
Ma, CX, Lacy, MQ, Rompaia, JF, et al. Acquired Fanconi Syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood 2004 104:40–2.Google Scholar
Maldonado, JE, Velosa, JA, Kyle, RA, et al. Fanconi syndrome in adults: A manifestation of a latent form of myeloma. Am J Med 1975; 58:354–64.Google Scholar
Cai, G, Sidhu, GS, Wieczorek, R, et al. Plasma cell dyscrasia with kappa light chain crystals in proximal tubular cells: A histological, immunofluorescence and ultrastructural study. Ultrastruct Pathol 2006; 30:315–9.Google Scholar
Decort, C, Bridoux, F, Touchard, G, Cogne, M. A monoclonal Vκl light chain responsible for incomplete proximal tubulopathy. Am J Kidney Dis 2003; 41:497–504.Google Scholar
Sirac, C, Bridoux, F, Essig, M, et al. Toward understanding renal Fanconi syndrome: Step by step advances through experimental models. In Herrera, GA (Ed.) Contributions to Nephrology Vol 169. Experimental Models for Renal Diseases. Pathogenesis and Diagnosis. Basel, Switzerland: Karger, 2011: 247–61.Google Scholar
Gu, X, Barrios, R, Cartwright, J, et al. Light chain crystal deposition as a manifestation of plasma cell dyscrasia: The role of immunoelectron microscopy. Hum Pathol 2003; 34:270–7.Google Scholar
Herrera, GA. Microanalytical techniques and image analysis in the evaluation of immunogold-labeled specimens at the ultrastructural level. Ultrastruct Pathol 1992; 16:127–35.Google Scholar
Venkataseshan, VS, Faraggiana, T, Hughson, MD, et al. Morphologic variants of light chain deposition disease in the kidney. Am J Nephrol 1988; 8:272–9.CrossRefGoogle ScholarPubMed
Aufman, J, Herrera, GA. Circulating monoclonal light chains and acute kidney injury: The role of the renal biopsy with emphasis on ultrastructural evaluation in assessing and understanding renal injury Ultrastruct Pathol 2015; 39:159–68.Google Scholar
Nasr, SH, Galgano, SJ, Markowitz, GS, et al. Immunofluorescence of pronase-digested sections: A valuable salvage technique for renal biopsies. Kidney Int 2006; 70:2148–51.CrossRefGoogle ScholarPubMed
Sewell, RL, Doreen, MS. Adult Fanconi syndrome progressing to multiple myeloma. J Clin Pathol 1984; 37:1256–8.Google Scholar
Haas, M, Spargo, BH, Wit, EJC, Meehan, SM. Etiologies and outcome of acute renal insufficiency in older adults: A renal biopsy study of 259 cases. Am J Kid Dis 2000; 35:433–47.CrossRefGoogle ScholarPubMed
Alpers, CE, Magil, AB, Gown, AM. Macrophage origin of the multinucleated cells of myeloma cast nephropathy. Am J Clin Pathol 1989; 92:662–5.CrossRefGoogle ScholarPubMed
Start, DA, Silva, FG, David, LD, D’Agati, V, Pirani, CL. Myeloma cast nephropathy: Immunohistochemical and lectin studies. Mod Pathol 1988; 1:336–47.Google Scholar
Uribe-Uribe, NO, Herrera, GA. Ultrastructure of tubular casts. Ultrastruct Pathol 2006; 30:159–66.Google Scholar
Soffer, O, Nassar, VH, Campbell, WG, Burke, E. Light chain cast nephropathy and acute renal failure associated with Rifampin therapy. Am J Med 1987; 82:1052–6.Google Scholar
Perazella, MA, Kashgarian, M, Cooney, E. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria. Clin Nephrol. 1998; 50:194–6.Google Scholar
Sanders, PW, Booker, BB. Pathobiology of case nephropathy from human Bence Jones proteins. J Clin Invest 1992; 89:630–9.Google Scholar
Madore, F. Does plasmapheresis have a role in the management of myeloma cast nephropathy? Nat Clin Pract (Nephrology) 2006; 2:406–7.Google Scholar
Neuman, V. Multiple plasma cell myeloma with crystalline deposits in the tumour cells and in the kidneys. J Path Bact 1949; 61:165–9.Google Scholar
Sickel, GW. Crystalline glomerular deposits in multiple myeloma. Am J Med 1959; 27:3546.CrossRefGoogle ScholarPubMed
Carstens, PHB, Woo, D. Crystalline glomerular inclusions in multiple myeloma. Am J Kidney Dis 1989; 14:56–60.Google Scholar
Nasr, SH, D’Agati, VD. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int 2006; 60:616–20.Google Scholar
Aucouturier, P, Khamlichi, AA, Touchard, G. Brief report: Heavy chain deposition disease. N Engl J Med 1993; 329:1389–93.Google Scholar
Bhargava, P, Rushin, JM, Rusnock, EJ, et al. Pulmonary light chain deposition disease: Report of five cases and review of the literature. Am J Surg Pathol 2007; 31:267–76.Google Scholar
Kambham, N, Markowitz, GS, Appel, GB, et al. Heavy chain deposition disease: The disease spectrum. Am J Kidney Dis 1999; 33:954–62.Google Scholar
Ronco, PM, Alyanakian, M-A, Mougenot, B, Aucouturier, P. Light chain deposition disease: A model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol 2001; 12:1558–65.Google Scholar
Silva, FG, Meyrier, A, Morel-Maroger, L, Pirani, C. Proliferative glomerulonephropathy in multiple myeloma. J Pathol 1980; 130:229–36.Google Scholar
Cheng, IKP, Ho, SKN, Chan, DTM, Chan, KW. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin heavy chain deposition. Am J Kidney Dis 1996; 28:283–8.Google Scholar
Yasuda, T, Fujita, K, Imai, H, et al. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol 1995; 44:394–9.Google Scholar
Herrera, GA, Turbat-Herrera, EA. Light/heavy chain deposition disease as a systemic disorder. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 153–66.Google Scholar
Nasr, SH, Valeri, AM, Cornell, LD, et al. Renal monoclonal immunoglobulin deposition disease: A report of 64 patients from a single institution. Clin J Am Soc Nephrol 2012; 7:231–9.Google Scholar
Royal, V, Quint, P, Leblanc, M, et al. IgD heavy-chain deposition disease: Detection by laser microdissection and mass spectrometry. J Am Soc Nephrol 2015; 26:784–90.Google Scholar
Knobler, H, Kopolovic, J, Kleinman, Y, et al. Multiple myeloma presenting as dense deposit disease. Light chain nephropathy. Nephron 1983; 34:58–63.Google Scholar
Chang, A, Peutz-Kootstra, CJ, Richardson, CA, Alpers, CE. Expanding the pathologic spectrum of light chain deposition disease: A rare variant with clinical follow-up of 7 years. Mod Pathol 2005; 18:998–1004.Google Scholar
Markowitz, GS, Lin, J, Valeri, AM, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 2002; 33:837–45.Google Scholar
Mai, HL, Sheikh-Hamad, D, Herrera, GA, Gu, X, Truong, L. Immunoglobulin heavy chain can be amyloidogenic: Morphologic characterization, including immunoelectron microscopy. Am J Surg Pathol 2003; 27:541–5.CrossRefGoogle ScholarPubMed
Nasr, SH, Said, SM, Valeri, AM, et al. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int 2013; 83:463–70.Google Scholar
Picken, MM. Non-light-chain immunoglobulin amyloidosis: Time to expand or refine the spectrum to include light+heavy chain amyloidosis? Kidney Int 2013; 83:353–6.Google Scholar
Dember, LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17:3458–71.Google Scholar
Dikman, SH, Churg, J, Kahn, T. Morphologic and clinical correlates in renal amyloidosis. Hum Pathol 1981; 12:160–6.CrossRefGoogle ScholarPubMed
Novak, L, Cook, WJ, Herrera, GA, Sanders, PW. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant 2004; 19:3050–3.Google Scholar
Sethi, S, Vrana, JA, Theis, JD, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 2012; 82:228–34.Google Scholar
Veeramachaneni, R, Gu, X, Herrera, GA. Atypical amyloidosis: Diagnostic challenges and the role of immunoelectron microscopy in diagnosis. Ultrastruct Pathol 2004; 28:75–82.Google Scholar
Picken, MM, Herrera, GA. Thioflavin T stain: an easier and more sensitive method for amyloid detection. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 225–7.Google Scholar
Clement, CG, Truong, LD. An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Hum Pathol 2014; 45:1766–72.Google Scholar
Said, SM, Sethi, S, Valeri, AM, et al. Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 2013; 8:1515–23.Google Scholar
Picken, MM, Herrera, GA. The burden of “sticky” amyloid typing challenges. Arch Pathol Lab Med 2007; 131:850–1.CrossRefGoogle ScholarPubMed
Gilbertson, JA, Gillmore, JD, Hawkins, PN. Amyloid typing: experience from a large referral centre. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations, 2nd edn., Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 273–83.Google Scholar
Benson, MD. LECT2 amyloidosis. Kidney Int 2010; 77:757–9.Google Scholar
Larsen, CP, Walker, PD, Weiss, DT, Solomon, A. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int 2010; 77:816–9.Google Scholar
Benson, MD. The hereditary amyloidoses. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 65–80.Google Scholar
Verga, L, Morbini, P, Palladini, G, Obici, L, Necchi, V, Paulli, M, Merlini, G. The role of immuno-electron microscopy in amyloid typing: The experience of the Pavia Referral Center. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 299–310.Google Scholar
Rocken, C, Shakespeare, A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 2002; 440:111–22.Google Scholar
Ombrello, AK, Aksentijevich, I. AA amyloidosis. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 31–53.Google Scholar
Pras, E, Aksentijevich, I, Gruberg, L, et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 1992; 326:1509–13.Google Scholar
Gregorini, G, Izzi, C, Obici, L, et al. Renal apolipoprotein A-I amyloidosis: A rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 2005; 16:3680–6.Google Scholar
Tan, CD, Rodriguez, ER. Cardiac amyloidosis. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 391–411.Google Scholar
Susantitaphong, P, Dember, LM, Jaber, BL. Dialysis-associated amyloidosis. In Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 81–94.Google Scholar
Batuman, V, Verroust, PJ, Navar, GL. Myeloma light chains are ligands for cubilin (gp 280). Am J Phys Renal Physiol 1998; 275:F246–54.Google Scholar
Herrera, GA. Low molecular weight proteins and the kidney. Physiological and pathological considerations. Ultrastruct Pathol 1994; 18:89–98.Google Scholar
Huang, Z-Q, Sanders, PW. Localization of a single binding site for immunoglobulin light chains on human Tamm–Horsfall glycoprotein. J Clin Invest 1997; 99:732–8.Google Scholar
Ying, WZ, Sanders, PW. Mapping the binding domain of immunoglobulin light chains for Tamm–Horsfall protein. Am J Pathol 2001; 158:1859–66.Google Scholar
Zhu, L, Herrera, GA, Murphy-Ullrich, JE, Huang, ZQ, Sanders, PW. Pathogenesis of glomerulosclerosis in light chain deposition disease: Role for transforming growth factor-β. Am J Pathol 1995; 147:375–85.Google Scholar
Turbat-Herrera, EA, Isaac, J, Sanders, PW, Truong, LD, Herrera, GA. Integrated expression of glomerular extracellular proteins and β1 integrins on monoclonal light chain-related renal diseases. Mod Pathol 1997; 10:485–95.Google Scholar
Herrera, GA, Schultz, J, Soong, S, Sanders, PW. Growth factors in monoclonal light chain-related renal diseases. Hum Pathol 1994; 25:883–9.Google Scholar
Keeling, J, Herrera, GA. An in vivo model of light chain deposition disease. Kidney Int 2009; 75:634–45.Google Scholar
Keeling, J, Herrera, GA. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage. Kidney Int 2005; 68:1590–603.Google Scholar
Solomon, A, Weiss, DT. Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL-amyloidosis). Int J Exp Clin Invest 1995; 2:269–79.Google Scholar
Sirac, C, Bridoux, F, Carrion, C, et al. Role of the monoclonal K chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 2006; 108:536–43.Google Scholar
Gonzalez-Andrade, M, Becerril-Lujan, B,Sanchez-Lopez, R, et al. Mutational and genetic determinants of λ6 light chain amyloidogenesis. FEBS J 2013; 280:6173–83.Google Scholar
Bellotti, V, Mangione, P, Merlini, G. Review: Immunoglobulin light chain amyloidosis – The archetype of structural and pathogenic variability. J Struct Biol 2000; 130:280–9.Google Scholar
Gu, M, Wilton, R, Stevens, FJ. Diversity and diversification of light chains in myeloma: the spectre of amyloidogenesis by proxy. In Herrera, GA (Ed.) The Kidney in Plasma Cell Dyscrasias. Contributions to Nephrology series. Basel, Switzerland: S Karger, 2007, 156–81.Google Scholar
Decourt, C, Touchard, G, Preud’homme, JL, et al. Complete primary sequences of two (lambda) immunoglobulin light chains in myelomas with nonamyloid (Randall-Type) light chain deposition disease. Am J Pathol 1998; 153:313–8.CrossRefGoogle ScholarPubMed
Khamlichi, AA, Aucouturier, P, Preud’Homme, JL, Cogne, M. Structure of abnormal heavy chains in human heavy chain deposition disease. Eur J Biochem 1995;229:54–60.Google Scholar
Comenzo, RL, Zhang, Y, Martinez, C, Osman, K, Herrera, GA. The tropism of organ involvement in primary systemic amyloidosis: Contributions of Ig VL germline gene use and clonal plasma cell burden. Blood 2001; 98:714–20.Google Scholar
Omtvedt, LA, Bailey, D, Renouf, DV. Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid 2000; 7:227–44.Google Scholar
Heilman, RL, Velosa, JA, Holley, KE, Offord, KP, Kyle, RA. Long-term follow-up and response to chemotherapy in patients with light chain deposition disease. Am J Kidney Dis 1992; 20:34–41.Google Scholar
Masai, R, Wakui, H, Togashi, M, et al. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 2009; 71:9–20.Google Scholar
Royer, B, Arnulf, B, Martinez, F, et al. High dose chemotherapy in light and heavy chain deposition disease. Kidney Int 2004; 65:642–8.Google Scholar
Kumar, S. Stem cell transplantation for multiple myeloma. Curr Opin Oncol 2009; 21:162–70.Google Scholar
Montseny, JJ, Kleinkuecht, D, Meyrier, A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 1998; 13:1438–45.Google Scholar
Hotta, O, Taguma, Y. Resolution of nodular glomerular lesions in a patient with light-chain nephropathy. Nephron 2002; 91:504–5.Google Scholar
Komatsuda, A, Wakui, H, Ohtani, H, et al. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy. Am J Kidney Dis 2000; 35:1–5.Google Scholar
Leung, N, Lager, DJ, Gertz, MA, et al. Long-term outcome of renal transplantation in light chain deposition disease. Am J Kidney Dis 2004; 43:147–53.Google Scholar
Short, AK, O’Donoghill, DJ, Ried, HN, Short, CD, Roberts, IS. Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am J Nephrol 2001; 21:237–40.Google Scholar
Goldsmith, DJA, Sandooran, D, Short, MD, Mallick, NP, Johnson, RWG. Twenty-one years survival with systemic AL-amyloidosis. Am J Kidney Dis 1996; 28:278–82.Google Scholar
Kyle, RA, Gertz, MA. Primary systemic amyloidosis. Sem Haematol 1995; 32:45–59.Google Scholar
Gertz, MA, Kyle, RA, Greipp, PR. Response rates and survival in primary systemic amyloidosis. Blood 1991; 77:257–62.Google Scholar
Gertz, MA, Kyle, RA, O’Fallon, M. Dialysis support of patients with primary systemic amyloidosis. Arch Intern Med 1992; 152:2245–50.Google Scholar
Dember, LM, Sanchorwala, V, Comenzo, RL, et al. Effect of dose-intensive intraveneous melphalan and autogous blood stem cell transplantation in AL-amyloidosis-associated renal disease. Ann Intern Med 2001; 134:746–53.Google Scholar
Skinner, M, Sauchoranala, V, Seldin, DC. High-dose intravenous melphalan and autologous stem cell transplantation in patients with AL-amyloidosis: an eight year study. Ann Intern Med 2004; 40:85–93.Google Scholar
Schonlaud, SO, Lockhorst, H, Buzyn, A, et al. Allogenic and syngeneic hematopoetic cell transplantation in patients with amyloid light-chain amyloidosis: A report from the European Group for Blood and Marrow Transplantation. Blood 2006; 107:2578–84.Google Scholar
Hauck, W, Dember, LM, Hawkins, PN, et al. A prospective analysis of demography, etiology, and clinical findings of AA amyloidosis patients enrolled in the International Clinical Phase II/III Fibrillex study. In: Grateau, C, Kyle, RA Skinner, M (Eds.) Amyloid and Amyloidosis. Boca Raton, FL: CRC Press; 2005, 179–81.Google Scholar
Lobato, I, Ventura, A, Beirao, I. End-stage renal disease in familial amyloidosis. ATTR Val 30 Met: A definite indication to combined liver-kidney transplantation. Transplant Proc 2003; 35:1116–20.Google Scholar
Hartmann, A, Holdaas, H, Fauchald, P, et al. Fifteen years’ experience with renal transplantation in systemic amyloidosis. Transplant Int 1992; 5:15–8.Google Scholar
Pasternack, A, Ahonen, J, Kuhlback, B. Renal transplantation in 45 patients with amyloidosis. Transplantation 1986; 42:598–601.Google Scholar
Harrison, KL, Alpers, CE, Davis, CL. De novo amyloidosis in a renal allograft: A case report and review of the literature. Am J Kidney Dis 1993; 22:468–76.Google Scholar
Le, QC, Wood, TC, Alpers, CE. De novo AL amyloid in a renal allograft. Am J Nephrol 1998; 18:67–70.Google Scholar
Nasr, SH, Markowitz, GS, Stokes, MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune complex glomerulonephritis. Kidney Int 2004; 65:85–96.Google Scholar
Nasr, SH, Satoskar, A, Markowitz, GS, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009; 20:2055–64.Google Scholar
Guiard, E, Karras, A, Plaisier, E, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol 2011; 6:1609–16.Google Scholar
Herrera, GA. Renal lesions associated with plasma cell dyscrasias: Practical approach to diagnosis, new concepts and challenges. Arch Pathol Lab Med 2009; 133:249–67.Google Scholar
Sethi, S, Zand, L, Leung, N, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 2010; 5:770–82.Google Scholar
Nasr, SH, Seth, S, Cornell, LD, et al. Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol 2011; 6:122–32.Google Scholar
Bridoux, F, Desport, E, Fremeaux-Bacchi, V, et al. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: A fortuitous association? Clin J Am Soc Nephrol 2011; 6:2165–74.Google Scholar
Sepandj, F, Trillo, A. Dense deposit disease in association with monoclonal gammopathy of unknown significance. Nephrol Dial Transplant 1996; 11:2309–12.Google Scholar
Herrinton, LJ, Weiss, NS. Incidence of Waldenstrom’s macroglobulinemia. Blood 1993; 82:3148–50.Google Scholar
Dimopoulos, MA, Galani, E, Matsouka, C. Waldenström’s macroglobulinemia. Hem/Onc Clin N Amer 1999; 13:1351–66.Google Scholar
Gertz, MA, Kyle, RA, Noel, P. Primary systemic amyloidosis: a rare complication of immunoglobulin monoclonal gammopathies and Waldenstrom’s macroglobulinemia. J Clin Oncol 1993; 11:914–20.Google Scholar
Dutcher, TF, Fahey, JL. The histopathology of the macroglobulinemia of Waldenstrom. J Natl Cancer Inst 1959; 22:887–901.Google Scholar
Morel-Maroger, L, Bash, A, Danon, F, Verroust, P, Richet, G. Pathology of the kidney in Waldenstrom’s macroglobulinemia. Study of sixteen cases. N Engl J Med 1970; 283:123–9.Google Scholar
Argani, I, Kipkie, GF. Macroglobulinemic nephropathy. Am J Med 1964; 36:151–7.Google Scholar
Audard, V, Georges, B, Vanhille, P, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol 2008; 3:1339–49.Google Scholar
Grossman, ME, Bria, MJ, Goldwein, MI, Hill, G, Goldberg, M. Giant kidneys in Waldenstrom’s macroglobulinemia. Arch Intern Med 1977; 137:1613–5.Google Scholar
Isaac, J, Herrera, GA. Cast nephropathy in a case of Waldenstrom’s macroglobulinemia. Nephron 2002; 91:512–5.Google Scholar
Gertz, MA. Waldenstrom macroglobulinemia: A review of therapy. Am J Hematol 2005; 79:147–57.Google Scholar
Anagnostopoulos, A, Giralt, S. Stem cell transplantation (SCT) for Waldenstrom’s macroglobulinemia (WM). Bone Marrow Transplant 2002; 29:943–7.Google Scholar
Iskandar, SS, Herrera, GA. Glomerulopathies with organized deposits. Sem Diag Pathol 2002; 19:116–32.Google Scholar
Howell, D, Gu, X, Herrera, GA. Organized deposits and look-alikes. Ultrastruct Pathol 2003; 27:295–312.Google Scholar
Herrera, GA, Turbat-Herrera, EA. Renal diseases with organized deposits: An algorithmic approach to classification and diagnosis. Arch Pathol Lab Med 2010; 134:512–31.Google Scholar
Sethi, S, Theis, JD, Vrana, JA, et al. Laser microdissections and proteomic analysis of amyloidosis, cryoglobulinemic glomerulopathy, fibrillary glomerulonephritis and immunotactoid glomerulopathy. Clin J Am Soc Nephrol 2013; 18:915–21.Google Scholar
Sethi, S, Vrana, JA, Theis, JD, Dogan, A. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens 2013; 22:273–80.Google Scholar
Alpers, C. Fibrillary glomerulonephritis and immunotactoid glomerulopathy: Two entities, not one. Am J Kidney Dis 1993; 22:448–51.Google Scholar
Fogo, A, Qureshi, N, Horn, RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993; 22:367–77.Google Scholar
Rosenstock, JL, Markowitz, GS, Valeri, AM, et al. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int 2003; 63:1450–61.Google Scholar
Rosenmann, E, Eliakim, M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron 1977; 18:301–8.Google Scholar
Duffy, JL, Khurana, E, Susin, M, Gomez-Leon, G, Churg, J. Fibrillary renal deposits and nephritis. Am J Pathol 1983; 113:279–90.Google Scholar
Alpers, CE, Rennke, HG, Hopper, J, Biava, CG. Fibrillary glomerulonephritis: An entity with unusual immunofluorescence features. Kidney Int 1987; 31:781–9.Google Scholar
Adeyi, OA, Sethi, S, Rennke, HG. Fibrillary glomerulonephritis: A report of 2 cases with extensive glomerular and tubular deposits. Hum Pathol 2001; 32:660–3.Google Scholar
Nasr, SH, Valeri, AM, Cornell, LD. Fibrillary glomerulonephritis: A report of 66 cases from a single institution. Clin J Am Soc Nephrol 2011; 6:773–84.Google Scholar
Iskandar, SS, Falk, RJ, Jennette, C. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992; 42:1401–7.Google Scholar
Yang, GCH, Nieto, R, Stachura, I, Gallo, GR. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo-red-negative amyloid-like fibrils of fibrillary glomerulopathy. Am J Pathol 1992; 141:409–19.Google Scholar
Olesnicky, L, Doty, SB, Bertani, T, Pirani, CL. Tubular microfibrils in the glomeruli of membranous nephropathy. Arch Pathol Lab Med 1984; 108:902–5.Google Scholar
Rosenmann, E, Brisson, ML, Bercovitch, DD, Rosenberg, A. Atypical membranous glomerulonephritis with fibrillary subepithelial deposits in a patient with malignant lymphoma. Nephron 1988; 48:226–30.Google Scholar
Herrera, GA, Turbat-Herrera, EA. Differential diagnosis of amyloid in surgical pathology: organized deposits and other materials in the differential diagnosis of amyloidosis. Picken, MM, Dogan, A, Herrera, GA (Eds.) Amyloid and Related Disorders: Pathology and Clinical Correlations. Current Clinical Pathology series. Switzerland: Humana Press, Springer, 2015, 135–52.Google Scholar
Samanigo, M, Nadasdy, GM, Laszik, Z. Outcome of renal transplantation in fibrillary glomerulonephritis. Clin Nephrol 2001; 55:159–66.Google Scholar
Isaac, J, Herrera, GA, Shihab, FS. De-novo fibrillary glomerulopathy in the renal allograft of a patient with systemic lupus erythematosus. Nephron 2001; 87:365–8.Google Scholar
Czarnecki, PG, Lager, DJ, Leung, N, et al. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int 2009; 75:420–7.Google Scholar
Sohar, E, Ravid, M, Ben-Shaul, Y, Reshef, T, Gafni, J. Diabetic fibrillosis. Am J Med 1970; 49:64–9.Google Scholar
Gonul, II, Gough, J, Jim, K, Benediktsson, H. Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus. Int Urol Nephrol 2006; 38:767–72.Google Scholar
Iskandar, S, Herrera, GA. Organized deposits. In Jennette, JC, Olson, JL, Silva, FG, D’Agati, VD (Eds.) Heptinstall’s Pathology of the Kidney. 7th ed. Philadelphia, PA: Wolters Kluwer, 2015; 1015–37.Google Scholar
Schwartz, MM, Korbet, SM, Lewis, EJ. Immunotactoid glomerulopathy. J Am Soc Nephrol 2002; 13:1390–7.Google Scholar
Herrera, GA, Ojemakinde, KO, Turbat-Herrera, EA, et al. Immunotactoid glomerulopathy and cryoglobulemic nephropathy: Two entities with many similarities. A unified conceptual approach. Ultrastruct Pathol 2015; 39:270–80.Google Scholar
Nasr, SH, Fidler, ME, Cornell, LD, et al. Immunotactoid glomerulopathy: Clinicopathologic and proteomic study. Nephrol Dial Trans 2012; 27:4137–46.Google Scholar
Dispenzieri, A, Gorevic, PD. Cryoglobulinemia. Hematol/Oncol Clinics North Am 1999; 13:1315–49.Google Scholar
Karras, A, Noel, LH, Droz, D, et al. Renal involvement in monoclonal (Type I) cryoglobulinemia: Two cases associated with IgG3κ cryoglobulin. Am J Kidney Dis 2002; 40:1091–6.CrossRefGoogle ScholarPubMed
D’Amico, G. Renal involvement in human hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54:650–71.Google Scholar
Golde, D, Epstein, W. Mixed cryoglobulins and glomerulonephritis. Ann Int Med 1968; 69:1221–7.Google Scholar
Pais, B, Panadés, MJ, Ramos, J, Montoliu, J. Glomerular involvement in Type I monoclonal cryoglobulinema. Nephrol Dial Transplant 1995; 10:130–2.Google Scholar
Verroust, P, Mery, JP, Morel-Maroger, L, Clauvel, JP, Richet, G. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG–IgM. Adv Nephrol 1971; 1:161–94.Google Scholar
Tornroth, T, Skrifvars, B. Ultrastructural changes in acute nonstreptococcal glomerulonephritis associated with mixed cryoglobulinemia. Exp Mol Pathol 1973; 19:160–7.Google Scholar
Feiner, H, Gallo, G. Ultrastructure in glomerulonephritis associated with cryoglobulinemia. Am J Path 1977; 88:145–55.Google Scholar
Ojemakinde, K, Turbat-Herrera, EA, Zeng, X, et al. The many faces of cryoglobulinemic nephropathy: a clinico-pathologic study of 47 cases with emphasis on the value of electron microscopy. Ultrastruct Pathol. 2014; 38:367–76.Google Scholar
Ogihara, T, Saruta, T, Saito, I, et al. Finger print deposits of the kidney in pure monoclonal IgG kappa cryoglobulinemia. Clin Nephr 1979; 12:186–90.Google Scholar
Cordonnier, D, Martin, H, Groslambert, P, Micouin, C. Mixed IgG–IgM cryoglobulinemia with glomerulonephritis. Am J Med 1975; 59:867–72.Google Scholar
Tarantino, A, Campise, M, Banfi, G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47:618–23.Google Scholar
Strøm, EH, Banfi, G, Krapf, R, et al. Glomerulopathy associated with predominant fibronectin: A newly recognized hereditary disease. Kidney Int 1995; 48:163–70.Google Scholar
Burgin, M, Hoffmann, E, Reutter, FW. Familial glomerulopathy with giant fibrillary deposits. Virchows Arch A Pathol Anat Histol 1980; 388:313–26.Google Scholar
Assman, KJM, Loene, RAP. Familial glomerulonephritis characterized by massive deposits of fibronectin. AM J Kidney Dis 1995; 25:781–91.Google Scholar
Hilderbrandt, F, Strahm, B, Prochoroff, A. Glomerulopathy associated with predominant fibronectin deposits: Exclusion of the genes for fibronectin, villin and desmin as causative genes. Am J Med Genet 1996; 63:323–7.Google Scholar
Castelletti, F, Donadelli, R, Banterla, F, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci U S A 2008; 105:2538–43.Google Scholar
Gemperle, O, Neuweiler, J, Reutter, FW. Familial glomerulopathy with giant fibrillary (fibronectin positive) deposits: 15-year follow-up on a large kindred. Am J Kidney Dis 1996; 28:668–75.Google Scholar
Dombros, N, Katz, A. Nail patella-like renal lesion in the absence of skeletal abnormalities: Report of a kindred. Am J Kidney Dis 1982; 1:237–40.Google Scholar
Ikeda, K, Yokoyama, H, Tomosugi, N, et al. Primary glomerular fibrosis: A new nephropathy caused by diffuse intraglomerular increase in atypical Type III collagen fibers. Clin Nephrol 1990; 33:155–9.Google Scholar
Salcedo, JR. An autosomal recessive disorder with glomerular basement membrane abnormalities similar to those seen in the nail patella syndrome: Report of a kindred. Am J Med Genet 1984; 19:579–84.Google Scholar
Imbasciati, E, Gherardi, G, Morozumi, K, et al. Collagen Type III glomerulopathy: A new idiopathic glomerular disease. Am J Nephrol 1991; 11:422–9.Google Scholar
Gubler, MC, Dommergues, JP, Foulard, M, et al. Collagen Type III glomerulopathy: A new type of hereditary nephropathy. Pediatr Nephrol 1993; 7:354–60.Google Scholar
Yasuda, T, Imai, H, Nakamoto, Y, et al. Collagenofibrotic glomerulopathy: A systemic disease. Am J Kidney Dis 1999; 33:123–7.Google Scholar
Tamura, H, Matsuda, A, Kidoguchi, N, et al. A family with two sisters with collagenofibrotic glomerulonephropathy. Am J Kidney Dis 1996; 27:558–95.Google Scholar
Yoshioka, K, Takemura, T, Tohda, M, et al. Glomerular localization of Type III collagen in human kidney disease. Kidney Int 1989; 35:1203–11.Google Scholar
Striker, MML, Killen, PD, Chi, E, Striker, GE. The composition of glomerulosclerosis I. Studies in focal sclerosis, crescentic glomerulonephritis and membranoproliferative glomerulonephritis. Lab Invest 1984; 51:181–92.Google Scholar
Kronz, JD, Neu, AM, Nadasdy, T. When noncongophilic glomerular fibrils do not represent fibrillary glomerulonephritis: Nonspecific mesangial fibrils in sclerosing glomeruli. Clin Nephr 1998; 50:218–23.Google Scholar
Vogt, BA, Wyatt, RJ, Burke, BA, Simonton, S, Kashtan, CE. Inherited factor H deficiency and collagen Type III glomerulopathy. Pediatr Nephrol 1995; 9:11–5.Google Scholar
Scheinman, JI, Brown, DM, Michael, AF. Collagen synthesis by human glomerular cells in culture. J Am Soc Nephrol 1992; 2:1475–83.Google Scholar
Rørtveit, R, Lingaas, F, Bønsdorff, T, et al. A canine autosomal recessive model of collagen type III glomerulopathy. Lab Invest 2012; 92:1483–91.Google Scholar
Hoyer, JR, Michael, AP, Vermer, RL. Renal disease in nail–patella syndrome: Clinical and morphologic studies. Kidney Int 1972; 2:231–8.Google Scholar
Little, EM. Congenital absence in delayed development of the patella. Lancet 1897; 2:781–4.Google Scholar
Ben-Bassat, M, Cohen, L, Rosenfield, J. The glomerular basement membrane in the nail–patella syndrome. Arch Pathol 1971; 92:350–5.Google Scholar
Bennett, WM, Musgrave, JE, Campbell, RA, et al. The nephropathy of the nail–patella syndrome: Clinicopathologic analysis of 11 kindreds. Am J Med 1973; 54:304–19.Google Scholar
Hawkins, CF, Smith, OE. Renal dysplasia in a family with multiple hereditary abnormalities, including iliac horns. Lancet 1950; 1:803–8.Google Scholar
Lemley, KV: Kidney disease in nail–patella syndrome. Pediatr Nephrol 2009; 24:2345–54.Google Scholar
Roeckerath, W. [Hereditary osteo-onychodysplasia] Fortschr Geb Rontgenstr 1951; 75:700–12.Google Scholar
Schleutermann, DA, Bias, WB, Murdoch, JL, McKusick, VA. Linkage of the loci for the nail–patella syndrome and adenylate kinase. Am J Hum Genet 1969; 21:606–30.Google ScholarPubMed
Marini, M, Bocciardi, R, Gimelli, S, et al. A spectrum of LMX1B mutations in nail–patella syndrome: New point mutations, deletion, and evidence of mosaicism in unaffected parents. Genet Med 2010; 12:431–9.Google Scholar
Ghoumid, J, Petit, F, Holder-Espinasse, M, et al. Nail–patella syndrome: Clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity. Eur J Hum Genet 2016; 24:44–52.Google Scholar
Steinberg, MH, Brugnara, C. Pathophysiological-based approaches to treatment of sickle cell disease. Ann Rev Med 2003; 54:89–112.Google Scholar
Ataga, KI, Orringer, EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63:205–11.Google Scholar
Flanagan, G, Packham, DK, Kincaid-Smith, P. Sickle cell disease and the kidney. Am J Kidney Dis 1993; 21:325–7.Google Scholar
Pham, P-TT, Pham, P-CT, Wilkinson, AH, Lew, SQ. Renal abnormalities in sickle cell disease. Kidney Int 2000; 57:1–8.Google Scholar
Scheinman, JI. Sickle cell disease and the kidney. Semin Nephrol 2003; 23:66–76.Google Scholar
Wigfall, DR, Ware, RE, Burchinal, MR, Kinney, TR, Foreman, JW. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 2000; 136:749–53.Google Scholar
Wong, WY, Elliott-Mills, D, Powars, D. Renal failure in sickle cell anemia. Hematol Oncol Clin North Am 1996; 10:1321–31.Google Scholar
Bhathena, DB, Soundheimer, JH. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: Morphology and pathogenesis. J Am Soc Nephrol 1991; 1:1241–52.Google Scholar
Iskandar, SS, Morgann, RG, Browning, MC, Lorentz, WB. Membranoproliferative glomerulonephritis associated with sickle cell disease in two siblings. Clin Nephrol 1991; 35:47–51.Google Scholar
Balal, M, Paydas, S, Seyrek, N, Karayaylali, I. Different glomerular pathologies in sickle cell anemia. Clin Nephrol 2004;62:400–1.Google Scholar
Aviles, DH, Craver, R, Warrier, RP. Immunotactoid glomerulopathy in sickle cell anemia. Pediatric Nephrol 2001; 16:82–4.Google Scholar
Nasr, SH, Markowitz, GS, Sentman, RL, D’Agati, VD. Sickle-cell disease, nephrotic syndrome, and renal failure. Kidney Int 2006; 69:1276–80.Google Scholar
Platt, OS, Brambilla, DJ, Rosse, WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639–44.Google Scholar
Falk, RJ, Jennette, JC. Sickle cell nephropathy. Adv Nephrol Necker Hosp 1994; 23:133–47.Google Scholar
Naicker, S. Secondary glomerulonephritides. Ethn Dis 2003; 13:S125–30.Google Scholar
Mostofi, FK, Vorder Bruegge, CF, Diggs, LW. Lesions in kidneys removed for unilateral hematuria in sickle-cell disease. Arch Pathol 1957; 63:336–51.Google Scholar
Jung, DC, Kim, SH, Jung, SI, Hwang, SI, Kim, SH. Renal papillary necrosis: Review and comparison of findings at multi-director row CT and intravenous urography. Radiographics 2006; 26:1827–36.Google Scholar
Griffin, MD, Bergstralhn, EJ, Larson, TS. Renal papillary necrosis – A sixteen-year clinical experience. J Am Soc Nephrol 1995; 6:248–56.Google Scholar
Ahmed, SG, Ibrahim, UA. Haemoglobin-0S in sickle cell trait with papillary necrosis. Br J Haematol 2006; 135:415–6.Google Scholar
Alebiousu, CO. Renal papillary necrosis as first presentation of a Nigerian sickle cell patient. West Afr J Med 2002; 21:168–9.Google Scholar
Saborio, P, Scheinman, JI. Sickle cell nephropathy. J Am Soc Nephrol 1999; 10:187–92.Google Scholar
Guasch, A, Navarrete, J, Nass, K, Zayas, CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 2006; 17:2228–35.Google Scholar
Verani, RR, Conley, SB. Sickle cell glomerulopathy with focal segmental glomerulosclerosis. Child Nephrol Urol 1991; 11:206–8.Google Scholar
Vogler, C, Wood, E, Lane, P, et al. Microangiopathic glomerulopathy in children with sickle cell anemia. Pediatr Pathol Lab Med 1996; 16:275–84.Google Scholar
Simsek, B, Bayazit, AK, Ergin, M, et al. Renal amyloidosis in a child with sickle cell anemia. Pediatr Nephrol 2006; 21:877–9.Google Scholar
Pickhardt, PJ. Renal medullary carcinoma: An aggressive neoplasm in patients with sickle-cell disease. Nat Clin Pract Urol 2006; 3:279–83.Google Scholar
Sathyamoorthy, K, Teo, A, Atallah, M. Renal medullary carcinoma in a patient with sickle-cell disease. Nat Clin Pract Urol 2006; 3:279–83.Google Scholar
Patel, K, Livni, N, MacDonald, D. Renal medullary carcinoma, a rare cause of haematuria in sickle-cell disease. (Images in Hematology). Br J Haematol 2006; 132:1.Google Scholar
Johal, NS, Desai, D, Cuckow, PM. Renal medullary carcinoma: Beware of diagnosing a urinary tract infection in a young sickle cell patient. Hosp Med 2005; 66:114–5.Google Scholar
Seyrek, N, Paydas, S, Karayaylali, I, Tuncer, I, Sagliker, Y. Nephrotic syndrome in two cases with sickle cell nephropathy. Nephron 1996; 74:218.Google Scholar
Pardo, V, Strauss, J, Kramer, H, Ozawa, T, McIntosh, RM. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis. II. Clinicopathologic study of seven patients. Am J Med 1975; 59:650–9.Google Scholar
Martin, H, Steinberg, MD. Management of sickle cell disease. N Engl J Med 1999; 340:1021–30.Google Scholar
Ribot, S. Kidney transplant in sickle cell nephropathy. Int J Artif Organs 1999; 22:61–3.Google Scholar
Chatterjee, SN. National study on natural history of allografts in sickle cell disease or trait. Nephron 1980; 25:199–201.Google Scholar
Chatterjee, SN. National study in natural history of renal allograft in sickle disease or trait: A second report. Transplant Proc 1987; 19(Suppl):33–5.Google Scholar
Warady, BA, Sullivan, EK. Renal transplantation in children with sickle cell disease: A report of the North American Pediatric Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998; 2:130–3.Google Scholar
Ojo, AO, Govaerts, TC, Schmouder, RL, et al. Renal transplantation in end-stage sickle cell nephropathy. Transplantation 1999; 67:291–5.Google Scholar
Spector, D, Zachary, JB, Steriott, S, Milan, J. Painful crises following renal transplantation in sickle cell anemia. Am J Med 1978; 64:835–9.Google Scholar
Montgomery, R, Zibari, G, Hill, GS, Ratner, LE. Renal transplantation in patients with sickle cell nephropathy. Transplantation 1994; 58:618–20.Google Scholar
Miner, DJ, Jorkasky, DK, Perloff, LJ, Grossman, RA, Tomaszewski, JE. Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 1987; 10:306–13.Google Scholar
Iannone, R, Ohene-Frempong, K, Fuchs, EJ, Casella, JF, Chen, AR 2005. Bone marrow transplantation for sickle cell anemia: Progress and prospects. Pediatric Blood Cancer 2005; 44:436–40.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×